当前位置:首页 - 行情中心 - 融捷健康(300247) - 财务分析 - 现金流量表

融捷健康

(300247)

  

流通市值:28.54亿  总市值:28.54亿
流通股本:8.04亿   总股本:8.04亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金451,698,793.8281,898,156.98938,907,602.39622,203,144.54
  收到的税费返还30,335,858.775,860,323.9118,814,199.5714,015,839.05
  收到其他与经营活动有关的现金16,797,724.696,316,400.5719,212,924.3116,763,455.28
  经营活动现金流入小计498,832,377.26294,074,881.46976,934,726.27652,982,438.87
  购买商品、接受劳务支付的现金308,172,785.8155,531,894.69632,554,115.98439,618,609.45
  支付给职工以及为职工支付的现金94,048,032.7865,085,549.32124,795,67897,001,250.53
  支付的各项税费45,485,632.828,947,577.9549,231,190.2329,288,382.98
  支付其他与经营活动有关的现金33,776,992.878,862,630.1154,637,600.6244,809,532.9
  经营活动现金流出小计481,483,444.25258,427,652.07861,218,584.83610,717,775.86
  经营活动产生的现金流量净额17,348,933.0135,647,229.39115,716,141.4442,264,663.01
二、投资活动产生的现金流量:
  收回投资收到的现金441,339,922.1310,240,830.48315,553,279.29573,208,200
  取得投资收益收到的现金7,252,764.082,189,143.29,532,793.5113,983,609.93
  处置固定资产、无形资产和其他长期资产收回的现金净额14,00014,000205,323.0827,130.2
  投资活动现金流入小计448,606,686.18312,443,973.68325,291,395.88587,218,940.13
  购建固定资产、无形资产和其他长期资产支付的现金9,610,570.787,496,651.419,873,000.525,223,820.81
  投资支付的现金384,200,931.54261,816,680324,405,395.35606,005,880
  投资活动现金流出小计393,811,502.32269,313,331.41334,278,395.87611,229,700.81
  投资活动产生的现金流量净额54,795,183.8643,130,642.27-8,986,999.99-24,010,760.68
三、筹资活动产生的现金流量:
  支付其他与筹资活动有关的现金7,888,421.39-11,132,887.028,609,201.54
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计7,888,421.39-11,132,887.028,609,201.54
  筹资活动产生的现金流量净额平衡项目0-00
  筹资活动产生的现金流量净额-7,888,421.39--11,132,887.02-8,609,201.54
四、汇率变动对现金及现金等价物的影响-8,282,580.77-4,420,616.24-7,900,101.42-2,372,546.92
五、现金及现金等价物净增加额55,973,114.7174,357,255.4287,696,153.017,272,153.87
  加:期初现金及现金等价物余额268,019,687.42268,019,687.42180,323,534.41180,323,534.41
  期末现金及现金等价物余额323,992,802.13342,376,942.84268,019,687.42187,595,688.28
补充资料:
  净利润64,465,957.95-108,145,094.75-
  资产减值准备-2,415,848.69-5,888,909.4-
  固定资产和投资性房地产折旧6,842,514.78-13,533,473.25-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧6,842,514.78-13,533,473.25-
  无形资产摊销1,215,982.37-2,441,700.22-
  长期待摊费用摊销254,346.94-372,773.9-
  处置固定资产、无形资产和其他长期资产的损失-110,290.16-104,472.64-
  固定资产报废损失--56,633-
  公允价值变动损失-11,408,546.82--514,727.39-
  财务费用758,274.28-7,576,389.48-
  投资损失-3,297,712.61--1,384,477.15-
  递延所得税286,590.95--2,756,805.83-
  其中:递延所得税资产减少1,261,792.37--16,318,855.2-
    递延所得税负债增加-975,201.42-13,562,049.37-
  存货的减少-95,061,158.4--28,452,944.76-
  经营性应收项目的减少57,485,704.55--21,076,671.14-
  经营性应付项目的增加-10,995,498.9-20,285,374.86-
  其他2,198,469.67---
  现金的期末余额323,992,802.13-268,019,687.42-
  减:现金的期初余额268,019,687.42-180,323,534.41-
  现金及现金等价物的净增加额55,973,114.71-87,696,153.01-
公告日期2026-08-262026-04-282026-04-222025-10-27
审计意见(境内)标准无保留意见
TOP↑